Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1989 1
1990 2
1991 3
1992 3
1993 6
1994 10
1995 6
1996 10
1997 12
1998 5
1999 11
2000 15
2001 13
2002 13
2003 20
2004 23
2005 24
2006 26
2007 30
2008 27
2009 35
2010 41
2011 61
2012 78
2013 66
2014 85
2015 99
2016 83
2017 85
2018 91
2019 98
2020 94
2021 61
2022 19
2023 15
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

1,115 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Localized Resectable Adult Hepatocellular Carcinoma"
Page 1
Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J, Wen Z. Ding J, et al. BMC Cancer. 2021 Oct 29;21(1):1157. doi: 10.1186/s12885-021-08904-3. BMC Cancer. 2021. PMID: 34715816 Free PMC article.
BACKGROUND: Hepatocellular carcinoma (HCC) incidences have been increasing in the United States. ...After adjusting for patient and tumor characteristics and treatment difference, period of diagnosis retained an independent factor for improved DSS and its prognostic …
BACKGROUND: Hepatocellular carcinoma (HCC) incidences have been increasing in the United States. ...After adjusting for patien …
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study.
Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, Fowers K, Lewandowski R, Padia SA. Salem R, et al. Hepatology. 2021 Nov;74(5):2342-2352. doi: 10.1002/hep.31819. Epub 2021 Jun 11. Hepatology. 2021. PMID: 33739462 Free PMC article.
Radioembolization served as neoadjuvant therapy for transplantation or resection in 21.0% (34 of 162) and 6.8% (11 of 162) of patients, respectively, and as primary treatment for all others. ...Three-year overall survival was 86.6% for all patients and 92.8% for those neoa …
Radioembolization served as neoadjuvant therapy for transplantation or resection in 21.0% (34 of 162) and 6.8% (11 of 162) of patient …
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Hu B, et al. Clin Cancer Res. 2014 Dec 1;20(23):6212-22. doi: 10.1158/1078-0432.CCR-14-0442. Epub 2014 Sep 30. Clin Cancer Res. 2014. PMID: 25271081
PURPOSE: We developed a novel systemic immune-inflammation index (SII) based on lymphocyte, neutrophil, and platelet counts and explored its prognostic value in hepatocellular carcinoma (HCC). EXPERIMENTAL DESIGN: The SII was developed based on a retrospective study …
PURPOSE: We developed a novel systemic immune-inflammation index (SII) based on lymphocyte, neutrophil, and platelet counts and explored its …
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP, Xing KL, Fu JC, Ling YH, Li SH, Yu WS, Zhang YF, Zhong C, Wang JH, Chen ZY, Lu LH, Wei W, Guo RP. Lin WP, et al. JAMA Netw Open. 2021 Sep 1;4(9):e2125055. doi: 10.1001/jamanetworkopen.2021.25055. JAMA Netw Open. 2021. PMID: 34515782 Free PMC article.
IMPORTANCE: Because of tumor heterogeneity, traditional clinical variables remain insufficient to predict recurrence, which impairs long-term survival among patients undergoing radical hepatectomy for hepatocellular carcinoma (HCC). ...CONCLUSIONS AND RELEVAN …
IMPORTANCE: Because of tumor heterogeneity, traditional clinical variables remain insufficient to predict recurrence, which impairs l …
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
Pinyol R, Montal R, Bassaganyas L, Sia D, Takayama T, Chau GY, Mazzaferro V, Roayaie S, Lee HC, Kokudo N, Zhang Z, Torrecilla S, Moeini A, Rodriguez-Carunchio L, Gane E, Verslype C, Croitoru AE, Cillo U, de la Mata M, Lupo L, Strasser S, Park JW, Camps J, Solé M, Thung SN, Villanueva A, Pena C, Meinhardt G, Bruix J, Llovet JM. Pinyol R, et al. Gut. 2019 Jun;68(6):1065-1075. doi: 10.1136/gutjnl-2018-316408. Epub 2018 Aug 14. Gut. 2019. PMID: 30108162 Free PMC article. Clinical Trial.
OBJECTIVE: Sorafenib is the standard systemic therapy for advanced hepatocellular carcinoma (HCC). Survival benefits of resection/local ablation for early HCC are compromised by 70% 5-year recurrence rates. ...CONCLUSION: In BIOSTORM, only hepatocytic …
OBJECTIVE: Sorafenib is the standard systemic therapy for advanced hepatocellular carcinoma (HCC). Survival benefits of res …
Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.
Michelakos T, Kontos F, Sekigami Y, Qadan M, Cai L, Catalano O, Deshpande V, Patel MS, Yamada T, Elias N, Dageforde LA, Kimura S, Kawai T, Tanabe KK, Markmann JF, Yeh H, Ferrone CR. Michelakos T, et al. J Gastrointest Surg. 2021 Jul;25(7):1727-1735. doi: 10.1007/s11605-020-04765-6. Epub 2020 Aug 10. J Gastrointest Surg. 2021. PMID: 32779082
BACKGROUND: The survival benefit of negative margins for hepatocellular carcinoma (HCC) has been demonstrated. However, there is no consensus regarding the optimal resection margin width. ...Findings were similar in all subgroups analyzed ( 5 cm, > 5 cm, m …
BACKGROUND: The survival benefit of negative margins for hepatocellular carcinoma (HCC) has been demonstrated. However, there …
Magnetic resonance elastography-based prediction of hepatocellular carcinoma recurrence after curative resection.
Abe H, Midorikawa Y, Higaki T, Yamazaki S, Aramaki O, Nakayama H, Moriguchi M, Kanda T, Moriyama M, Okada M, Nishimaki H, Sugitani M, Tsuji S, Takayama T. Abe H, et al. Surgery. 2021 Jul;170(1):167-172. doi: 10.1016/j.surg.2021.02.027. Epub 2021 Mar 19. Surgery. 2021. PMID: 33752906
BACKGROUND: Liver stiffness measurement using magnetic resonance elastography can assess the severity of liver fibrosis, which is significantly associated with recurrence after curative resection for hepatocellular carcinoma. The aim of this prospective study …
BACKGROUND: Liver stiffness measurement using magnetic resonance elastography can assess the severity of liver fibrosis, which is significan …
Resectable and transplantable hepatocellular carcinoma: Integration of liver stiffness assessment in the decision-making algorithm.
Tortajada P, Doamba R, Cano L, Ghallab M, Allard MA, Ciacio O, Pittau G, Salloum C, Cherqui D, Adam R, Sa Cunha A, Azoulay D, Pascale A, Vibert E, Golse N. Tortajada P, et al. Surgery. 2022 Dec;172(6):1704-1711. doi: 10.1016/j.surg.2022.08.012. Epub 2022 Oct 12. Surgery. 2022. PMID: 36241470
BACKGROUND: Liver resection is a curative treatment for hepatocellular carcinoma (HCC) and an alternative to liver transplantation (LT). ...Patients experiencing early recurrence (<1 year) presented a significantly higher preoperative LSM (P = .06). CONCLU …
BACKGROUND: Liver resection is a curative treatment for hepatocellular carcinoma (HCC) and an alternative to liver tran …
Clinical correspondence to hepatocellular carcinoma-related lesions with atypical radiological pattern.
Higaki T, Midorikawa Y, Nakashima Y, Nakayama H, Matsuoka S, Moriyama M, Sugitani M, Takayama T. Higaki T, et al. Biosci Trends. 2017 Jul 24;11(3):340-345. doi: 10.5582/bst.2017.01110. Epub 2017 Jun 18. Biosci Trends. 2017. PMID: 28626210 Free article.
In patients at risk of hepatocarcinogenesis, tumors are frequently detected with atypical radiological patterns related to hepatocellular carcinoma (HCC) on imaging studies. Despite their high potential for malignancy, whether to resect such lesions immediate …
In patients at risk of hepatocarcinogenesis, tumors are frequently detected with atypical radiological patterns related to hepatocellular …
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, Busuttil RW. Zimmerman MA, et al. Arch Surg. 2008 Feb;143(2):182-8; discussion 188. doi: 10.1001/archsurg.2007.39. Arch Surg. 2008. PMID: 18283144 Review.
OBJECTIVE: To review the preoperative and postoperative variables that predict hepatocellular carcinoma (HCC) recurrence following orthotopic liver transplantation (OLT). DATA SOURCES: A collective review of the literature was conducted by searching the MEDLI …
OBJECTIVE: To review the preoperative and postoperative variables that predict hepatocellular carcinoma (HCC) recurrenc …
1,115 results